Futibatinib is a special FGFR inhibitor made just for cholangiocarcinoma with FGFR2 fusions. It stops FGFR signaling—a big deal in the growth of these cancer tumors. The drug is in 4 mg tablet form, and you’re supposed to take 20 mg each day.
You just take it once a day. Each bottle has 28 tablets, so it covers you for a whole month.
